Table 3.
Prox1 expression in malignant epithelial neoplasms.
| Tumor type | Positive/total | % positive |
|---|---|---|
| Breast, ductal carcinoma | 1/49 | 2 |
| Breast, lobular carcinoma | 0/5 | |
| Larynx, squamous cell carcinoma | 0/34 | |
| Lung, adenocarcinoma | 4/31 | 13 |
| Lung, squamous cell carcinoma | 0/15 | |
| Lung, small cell carcinoma | 5/12 | 42 |
| Malignant mesothelioma | 0/22 | |
| Liver, hepatocellular carcinoma | 4/25 | 16 |
| Liver, cholangiocarcinoma | 10/15 | 67 |
| Pancreas, adenocarcinoma | 0/20 | |
| Pancreas, islet cell tumor | 2/5 | 40 |
| Esophagus, squamous cell carcinoma | 0/26 | |
| Renal cell carcinoma | 0/25 | |
| Small intestine, sarcomatoid carcinoma | 0/12 | |
| Stomach, glandular adenocarcinoma | 3/38 | 8 |
| Stomach, signet ring cell carcinoma | 0/5 | |
| Colon, adenocarcinoma | 18/38 | 47 |
| Prostate, adenocarcinoma | 2/51 | 4 |
| Testis, seminoma | 0/25 | |
| Testis, embryonal carcinoma | 3/10 | 30 |
| Uterine cervix, squamous cell carcinoma | 0/27 | |
| Endometirium, adenocarcinoma | 2/16 | 13 |
| Ovary, adenocarcinoma | 1/33 | 3 |
| Thyroid, papillary carcinoma | 0/19 | |
| Total | 55/558 | 10 |